Paradoxical Response Developed during the Antituberculous Treatment in Tuberculous Pleurisy

被引:2
|
作者
Song, Eun Ju [1 ]
Baek, Dae Hyun [1 ]
Jung, Jun Young [1 ]
Lee, Sang Ryul [1 ]
Lee, Myong Ha [1 ]
Lee, Sung Hyuk [1 ]
Lee, Jae Hyung [1 ]
Lee, Ki Deok [1 ]
Lee, Byoung Hoon [1 ]
Kim, Sang Hoon [1 ]
机构
[1] Eulji Univ, Eulji Hosp, Coll Med, Dept Internal Med, 280-1,Hagye Dong, Seoul 139872, South Korea
关键词
Tuberculous pleurisy; Paradoxical response; Antitubercular agents;
D O I
10.4046/trd.2008.64.6.427
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: A paradoxical response is defined as the radiological and clinical worsening of a previous lesion or the development of new lesion after initial improvement during the process of antituberculous treatment. The related factors for the development of a paradoxical response in patients with tuberculous pleurisy are not certain. Methods: We selected patients with tuberculous pleurisy who had been treated for more than 4 months. The changes on the serial chest X-ray findings before and after treatment were reviewed. Paradoxical responses were regarded as any worsening or development of new lesion at least 2 weeks after the initiation of treatment. The baseline clinical characteristics and laboratory findings of the peripheral blood and pleural fluid were compared between the patients with a paradoxical response and the patients without a paradoxical response. Results: Paradoxical responses appeared in sixteen patients (21%) among the 77 patients. It took a mean of 38.6 days after the treatment and the time to resolve the paradoxical response was a mean of 32.1 days. For the patients with a paradoxical response, the median age was younger (30.5 years vs 39.0 years, respectively) and the lymphocytic percentage of white blood cells in the pleural fluid was higher (82.1% vs 69.6%, respectively) than for the patients without a paradoxical response. Conclusion: The development of a paradoxical response during the treatment of patients with tuberculous pleurisy was not rare and this was related with the age of the patients and the percentage of lymphocytic white blood cells in the pleural fluid.
引用
收藏
页码:427 / 432
页数:6
相关论文
共 50 条
  • [41] Development of contralateral pleural effusion during chemotherapy for tuberculous pleurisy
    Al-Ali, MA
    Almasri, NM
    SAUDI MEDICAL JOURNAL, 2000, 21 (06) : 574 - 576
  • [42] Sonographic septation: a predictor of sequelae of tuberculous pleurisy after treatment
    Lai, Y-F
    Su, M-C
    Weng, H-H
    Wu, J-T
    Chiu, C-T
    THORAX, 2009, 64 (09) : 806 - 809
  • [43] Treatment of free-flowing tuberculous pleurisy with intrapleural urokinase
    Cao, G-Q.
    Li, L.
    Wang, Y-B.
    Shi, Z-Z.
    Fan, D-Y.
    Chen, H-Y.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (11) : 1395 - 1400
  • [44] CONTRA-LATERAL PARADOXICAL PLEURAL EFFUSION DURING ANTITUBERCULOUS CHEMOTHERAPY
    Chopra, Vishal
    Singh, Urvinderpal
    Chopra, Dimple
    LUNG INDIA, 2008, 25 (03) : 124 - 125
  • [45] Study of paradoxical response to chemotherapy in tuberculous pleural effusion
    AlMajed, SA
    RESPIRATORY MEDICINE, 1996, 90 (04) : 211 - 214
  • [46] Paradoxical response to chemotherapy in tuberculous pleural effusion.
    Kumar, R
    Vasu, TS
    SAUDI MEDICAL JOURNAL, 2001, 22 (09) : 812 - 813
  • [47] Contralateral paradoxical response to chemotherapy in tuberculous pleural effusion
    Ahmed, AlaEldin Hassan
    Goddard, Sarah
    SUDAN JOURNAL OF MEDICAL SCIENCES, 2008, 3 (01): : 63 - 65
  • [48] Lymph node paradoxical enlargement during treatment for tuberculous spondylodiscitis (Pott's disease)
    Froissart, Antoine
    Pagnoux, Christian
    Cherin, Patrick
    JOINT BONE SPINE, 2007, 74 (03) : 292 - 295
  • [49] Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker
    Kang, Yixin
    Ge, Cheng
    Zhang, Huan
    Liu, Saizhe
    Guo, Hongyang
    Cui, Junchang
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 4467 - 4470
  • [50] Urokinase in the treatment of tuberculous pleurisy: a systematic review and meta-analysis
    Jing, Wenyao
    Weng, Ruolan
    Lin, Ping
    Luo, Miao
    BMC INFECTIOUS DISEASES, 2024, 24 (01)